GSAASeqSP: A toolset for gene set association analysis of RNA-Seq data

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Xiong, Qing ^a   Mukherjee, Sayan ^b   Furey, Terrence S ^c  

^a SOUTHWEST UNIVERSITY   (China)

^b Duke University   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TRANSCRIPTOME;

GENE EXPRESSION PROFILING; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; PROCEDURES; SEQUENCE ANALYSIS;

GENE EXPRESSION PROFILING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; RNA; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME;

EID: 84921326631     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06347     Document Type: Article

References (43)

1. Xiong, Q., Ancona, N., Hauser, E. R., Mukherjee, S. & Furey, T. S. Integrating genetic and gene expression evidence into genome-wide association analysis of gene sets. Genome Res 22, 386-397 (2012).
2. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102, 15545-15550 (2005).
3. Dinu, I. et al. Improving gene set analysis of microarray data by SAM-GS. BMC Bioinformatics 8, 242 (2007).
4. Kim, S. Y. & Volsky, D. J. PAGE: parametric analysis of gene set enrichment. BMC Bioinformatics 6, 144 (2005).
5. Luo, W., Friedman, M. S., Shedden, K., Hankenson, K. D. & Woolf, P. J. GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics 10, 161 (2009).
6. Boorsma, A., Foat, B. C., Vis, D., Klis, F. & Bussemaker, H. J. T-profiler: scoring the activity of predefined groups of genes using gene expression data. Nucleic Acids Res 33, W592-595 (2005).
7. Goeman, J. J., van de Geer, S. A., deKort, F. & van Houwelingen, H. C. Aglobal test for groups of genes: testing association with a clinical outcome. Bioinformatics 20, 93-99 (2004).
8. Mansmann, U. & Meister, R. Testing differential gene expression in functional groups. Goeman's global test versus an ANCOVA approach. Methods InfMed 44, 449-453 (2005).
9. Maglietta, R. et al. Statistical assessment of functional categories of genes deregulated in pathological conditions by using microarray data. Bioinformatics 23, 2063-2072 (2007).
10. Wang, Z., Gerstein, M. & Snyder, M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10, 57-63 (2009).
11. Wang, X. & Cairns, M. J. Gene set enrichment analysis of RNA-Seq data: integrating differential expression and splicing. BMC Bioinformatics 14 Suppl 5, S16 (2013).
12. Wang, X. & Cairns, M. J. SeqGSEA: a Bioconductor package for gene set enrichment analysis of RNA-Seq data integrating differential expression and splicing. Bioinformatics 30, 1777-1779 (2014).
13. Fridley, B. L. et al. Soft truncation thresholding for gene set analysis of RNA-seq data: Application to a vaccine study. Sci Rep 3, 2898 (2013).
14. Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14, 7 (2013).
15. Marioni, J. C., Mason, C. E., Mane, S. M., Stephens, M. & Gilad, Y. RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res 18, 1509-1517 (2008).
16. Bristol, J. A. et al. Biosynthesis of prothrombin: intracellular localization of the vitamin K-dependent carboxylase and the sites of gamma-carboxylation. Blood 88, 2585-2593 (1996).
17. Doggen, C. J., Rosendaal, F. R. & Meijers, J. C. Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII. Blood 108, 4045-4051 (2006).
18. Lerapetritou, M. G., Georgopoulos, P. G., Roth, C. M. & Androulakis, L. P. Tissuelevel modeling of xenobiotic metabolism in liver: An emerging tool for enabling clinical translational research. Clin Transl Sci 2, 228-237 (2009).
19. Qin, X. & Gao, B. The complement system in liver diseases. Cell Mol Immunol 3, 333-340 (2006).
20. Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J. & Schoonjans, K. Targeting bile-acid signalling for metabolic diseases. Nat Rev DrugDiscov 7, 678-693 (2008).
21. Goodman, D. S. Overview of current knowledge of metabolism of vitamin A and carotenoids. J Natl Cancer Inst 73, 1375-1379 (1984).
22. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747-752 (2000).
23. Schmidt, M., Hengstler, J. G., von Torne, C., Koelbl, H. & Gehrmann, M. C. Coordinates in the universe of node-negative breast cancer revisited. Cancer Res 69, 2695-2698 (2009).
24. Millour, J. et al. FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance. Oncogene 29, 2983-2995 (2010).
25. Sanders, D. A., Ross-Innes, C. S., Beraldi, D., Carroll, J. S. & Balasubramanian, S. Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells. Genome Biol 14, R6 (2013).
26. Myatt, S. S. & Lam, E. W. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 7, 847-859 (2007).
27. Koo, C. Y., Muir, K. W. & Lam, E. W. FOXM1: From cancer initiation to progression and treatment. Biochim Biophys Acta 1819, 28-37 (2012).
28. Raychaudhuri, P. & Park, H. J. FoxM1: a master regulator of tumor metastasis. Cancer Res 71, 4329-4333 (2011).
29. Fu, J., Bian, M., Jiang, Q. & Zhang, C. Roles of Aurora kinases in mitosis and tumorigenesis. Mol Cancer Res 5, 1-10 (2007).
30. Hontz, A. E. et al. Aurora a and B overexpression and centrosome amplification in early estrogen-induced tumor foci in the Syrian hamster kidney: implications for chromosomal instability, aneuploidy, and neoplasia. Cancer Res 67, 2957-2963 (2007).
31. Gully, C. P. et al. Aurora B kinase phosphorylates and instigates degradation of p53. Proc Natl Acad Sci U S A 109, E1513-1522 (2012).
32. Gully, C. P. et al. Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer. Mol Cancer 9, 42 (2010).
33. Franceschini, A. et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 41, D808-815 (2013).
34. Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol 11, R106 (2010).
35. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140 (2010).
36. Tarazona, S., Garcia-Alcalde, F., Dopazo, J., Ferrer, A. & Conesa, A. Differential expression in RNA-seq: a matter of depth. Genome Res 21, 2213-2223 (2011).
37. Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28, 511-515 (2010).
38. Maire, V. et al. Polo-like kinase 1: a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triplenegative breast cancer. Cancer Res 73, 813-823 (2013).
39. Wierer, M. et al. PLK1 signaling in breast cancer cells cooperates with estrogen receptor-dependent gene transcription. Cell Rep 3, 2021-2032 (2013).
40. Dillies, M. A. et al. A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis. Brief Bioinform (2012).
41. Gao, L., Fang, Z., Zhang, K., Zhi, D. & Cui, X. Length bias correction for RNA-seq data in gene set analyses. Bioinformatics 27, 662-669 (2011).
42. Fu, J. et al. Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expression. PLoS Genet 8, e1002431 (2012).
43. Pickrell, J. K. et al. Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature 464, 768-772 (2010).